Delivering patient-focused therapies from lab validation to the US market

From Molecule to Market

Delivering Value for Every Stakeholder

Contract Manufacturers
Pharmaceutical Companies
Wholesalers
Independent Pharmacies
Patients

U.S. Market Access

We buy and resell CMO/CDMO products through our established distribution network.

Regulatory Expertise for Foreign CMOs

We fill FDA regulatory gaps, helping foreign CMOs bring products to the U.S.

Product Innovation & Risk Sharing

We invest in product development, sometimes from the ground up, taking on the full financial risk.

Strategic Co-development

We use targeted ABM campaigns to partner with CMOs for approval initiatives, focusing on long-term growth.

Direct Distribution

We bypass large wholesalers, delivering products directly to prescribers and pharmacies.

Channel Access

We provide an alternative distribution network, enhancing market presence.

In-licensing Partnerships

We license select products that align with our sales channel and target market.

Strategic Collaboration

While co-development is rare, we collaborate on select market-expansion initiatives.

Specialty Product Supply

We focus on high-demand, patient-friendly medications.

Streamlined Partnerships

Fast, reliable logistics and customer-first support.

Sales Enablement

We help wholesalers position and sell TerrainRx products effectively.

Access Through Preferred Wholesalers

Pharmacies can source our products through their usual channels.

Patient-focused Products

Medications designed for ease of use, improved adherence, and positive clinical outcomes.

Pharmacy Profitability

Cost-effective, cGMP-compliant products with stable reimbursement models.

Targeted Local Support

We offer marketing and clinical awareness strategies when needed — without overcomplicating.

User-friendly Products

We prioritize ease of use, adherence, and improved quality of life.

Multiple Access Points

Available through independent pharmacies, medical practices, and, soon, telehealth.

Affordability & Coverage

We aim to minimize out-of-pocket costs and maximize insurance coverage.

Who We Are

Founded in 2012 and headquartered in Reno, Nevada, Terrain Pharmaceuticals, Inc. develops and delivers patient-focused therapies that advance clinical care.

Supported by global cGMP manufacturing, FDA-seasoned regulatory expertise, and nationwide distribution, Terrain combines advanced delivery platforms with rigorous formulation expertise while ensuring dependable access across the U.S. healthcare system.

Innovative Therapies,

Powered by Advanced Delivery

What Sets Us Apart

Quality Without Compromise

• cGMP partners in the U.S., EU, India & Asia
• Rigorous quality testing at every stage
• Dedicated Quality Unit with live lot tracking

Platform Innovation

• Hydrogel & drug-in-adhesive patches for steady, skin-friendly delivery
• Enhanced-bioavailability softgels
• Transmucosal formats to bypass first-pass metabolism

Targeted Distribution

National specialty wholesalers for breadth, plus physician-dispensed and independent-pharmacy programs for depth

Commercial Agility

• Complete regulatory pathways – ANDA, 505(b)(2), OTC
• Turnkey pricing, chargeback & compendia setup
• Flexible deal structures: licensing, co-promotion, asset acquisition

By The Numbers

20+ products

in active development across hydrogel & DIA patches, tablets, capsules and soft gels

11 launches

Slated for 2026, with rapid-launch timelines delivering new solutions across pain management, GI, and antibiotics within 5 to 10 months

8 manufacturing sites

across 4 continents provide supply resilience

3,000+ clinics

reached via physician-services channel, plus coast-to-coast wholesale coverage

Growth Pipeline Snapshot

Global Strategic Partnerships: Expanding our international footprint with the launch of targeted topical products.

Next-Gen Delivery Platforms: Expanding our 2026 portfolio with advanced hydrogel and DIA patches, tablets, and targeted topical solutions.

Rapid Commercial Scale-Up: Accelerating therapies from formulation to launch in just 5 to 10 months, ensuring resilient supply and rapid market entry.

See the full roadmap on our

Pipeline